OPA1 and familial dilated cardiomyopathy: Excessive mitochondrial fission in DCM patients and administration of the mitochondrial fusion promoter M1 dramatically enhanced mitochondrial fusion and increased Opa1 expression levels in diabetic hearts, improving myocardial fibrosis and OS in cardiomyocytes (123).